Synergistic enhancement of Toll-like receptor responses by NOD1 activation

European Journal of Immunology

Volumn 35, Issue 8, 2005, Pages 2471-2476

  van Heel, David A ^a   Ghosh, Subrata ^a   Butler, Matt ^a   Hunt, Karen ^a   Foxwell, Brian Michael J ^a   Mengin Lecreulx, Dominique ^b   Playford, Raymond J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

Human PBMC; Innate immunity; NOD1; NOD2; TLR

Indexed keywords

CELL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIGAND; PEPTIDE DERIVATIVE; PROTEIN NOD1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CYTOKINES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTORS;

EID: 23844508543     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526296     Document Type: Article

References (31)

1. Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., Viala, J., Tedin, K. et al., Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003. 300: 1584-1587.
2. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y. et al., An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003. 4: 702-707.
3. Girardin, S. E., Travassos, L. H., Herve, M., Blanot, D., Boneca, I. G., Philpott, D. J., Sansonetti, P. J. and Mengin-Lecreulx, D., Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 2003. 278: 41702-41708.
4. Travassos, L. H., Girardin, S. E., Philpott, D. J., Blanot, D., Nahori, M. A., Werts, C. and Boneca, I. G., Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004. 5: 1000-1006.
5. Girardin, S. E., Tournebize, R., Mavris, M., Page, A. L., Li, X., Stark, G. R., Bertin, J. et al., CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2001. 2: 736-742.
6. Kim, J. G., Lee, S. J. and Kagnoff, M. F., Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infect. Immun. 2004. 72: 1487-1495.
7. Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R. et al., Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004. 5: 1166-1174.
8. Hysi, P., Kabesch, M., Moffatt, M. F., Schedel, M., Carr, D., Zhang, Y., Boardman, B. et al., NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 2005. 14: 935-941.
9. McGovern, D. P., Hysi, P., Ahmad, T., van Heel, D. A., Moffatt, M. F., Carey, A., Cookson, W. O. and Jewell, D. P., Association between a complex insertion/deletion polymorphism in NOD1(CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 2005. 14: 1245-1250.
10. Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R. et al., Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 1999. 274: 14560-14567.
11. Yao, N. J., Park, W. S., Kim, S. Y., Reed, J. C., Son, S. G., Lee, J. Y. and Lee, S. H., Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 2002. 299: 652-658.
12. Ogura, Y., Saab, L., Chen, F. F., Benito, A., Inohara, N. and Nunez, G., Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease. Genomics 2003. 81: 369-377.
13. Nagao, S., Akagawa, K. S., Yamada, K., Yagawa, K., Tokunaga, T. and Kotani, S., Lack of response of marine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent. Microbiol. Immunol. 1990. 34: 323-335.
14. Pauleau, A. L. and Murray, P. J., Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell Biol. 2003. 23: 7531-7539.
15. Watanabe, T., Kitani, A., Murray, P. J. and Strober, W., NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 2004. 5: 800-808.
16. Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann L. and Karin, M., Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005. 307: 734-738.
17. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G. and Flavell, R. A., Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005. 307: 731-734.
18. Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S. and Nunez, G., Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF{kappa}B. J. Biol. Chem. 2001. 276: 4812-4818.
19. Traub, S., Kubasch, N., Morath, S., Kresse, M., Hartung, T., Schmidt, R. R. and Hermann, C., Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 2004. 279: 8694-8700.
20. Yang, S., Tamai, R., Akashi, S., Takeuchi, O., Akira, S., Sugawara, S. and Takada, H., Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 2001. 69: 2045-2053.
21. van Heel, D., Ghosh, S., Butler, M., Hunt, K., Lundberg, A., Ahmad, T., McGovern, D. et al., Muramyl dipeptide and Toll-like receptor sensitivity in NOD2 associated Crohn's disease. Lancet 2005. 365: 1794-1796.
22. Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S. and Takada, H., Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 2005. 7: 53-61.
23. Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Nunez, G., Janeway, C. A., Medzhitov, R. and Flavell, R. A., RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002. 416: 194-199.
24. Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y. and Nunez, G., An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 2000. 275: 27823-27831.
25. Abbott, D. W., Wilkins, A., Asara, J. M. and Cantley, L. C., The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 2004. 14: 2217-2227.
26. Chen, C. M., Gong, Y., Zhang, M. and Chen, J. J., Reciprocal cross talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 2004
27. Damiano, J. S., Oliveira, V., Welsh, K. and Reed, J. C., Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 2004 Pt.
28. Martinon, F., Agostini, L., Meylan, E. and Tschopp, J., Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 2004. 14: 1929-1934.
29. Vavricka, S. R., Musch, M. W., Chang, J. E., Nakagawa, Y., Phanvijhitsiri, K., Waypa, T. S., Merlin, D. et al., hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004. 127: 1401-1409.
30. + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods 2003. 278: 79-93.
31. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K. et al., Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 2003. 278: 5509-5512.